Accolade Welcomes Oshi Health to Trusted Partner Ecosystem

Rhea-AI Summary

Accolade (Nasdaq: ACCD) has announced a strategic partnership with Oshi Health, a virtual GI clinic, expanding its digestive health solutions alongside existing partner Cylinder. The collaboration aims to address the significant healthcare challenge of GI diseases, which affect 70 million Americans annually and generate $136 billion in healthcare costs.

The partnership tackles critical issues in GI care, including lengthy diagnosis waiting times (2-3 years on average) and access to comprehensive treatment. Oshi Health provides integrated care through virtual consultations with GI specialists, dietitians, and psychologists, achieving 92% symptom control rate within 10 weeks.

This initiative specifically targets digestive health conditions, which represent the second leading cause of workplace absences. Oshi Health's services are in-network with major insurance plans, and the partnership includes purpose-built integrations to improve access to specialized GI care for Accolade's customer base.

Positive

• Partnership expands access to specialized GI care services
• Oshi Health reports 92% success rate in symptom control
• In-network coverage with major insurance plans
• Addresses $136B market opportunity in GI healthcare

Negative

• None.

Insights

Financial Analyst

Accolade's new partnership with Oshi Health represents a strategic expansion of its healthcare ecosystem, specifically targeting the substantial digestive health market that affects 70 million Americans and drives $136 billion in annual healthcare costs. This partnership complements Accolade's existing relationship with Cylinder in the gastrointestinal (GI) care space, showing a deliberate focus on building comprehensive capabilities in high-cost, high-prevalence condition management.

The partnership addresses a significant pain point in healthcare delivery - GI conditions are the second leading cause of missed work and the leading cause of avoidable ER visits, representing a clear opportunity to reduce employer healthcare costs through better condition management. Oshi's reported 92% symptom control rate within 10 weeks suggests potential for meaningful impact on both direct medical costs and indirect productivity losses for Accolade's employer clients.

From a business perspective, this partnership enhances Accolade's value proposition in the competitive employer benefits space by addressing a common condition with substantial workplace impact. The integration of Oshi's specialized virtual care model into Accolade's platform potentially creates a more compelling offering for both existing and prospective clients. However, the announcement lacks specific financial projections or exclusivity terms, making the immediate revenue impact difficult to quantify. This appears to be part of Accolade's broader strategy to build a comprehensive healthcare navigation and specialty care coordination platform rather than a transformative single partnership.

Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions

SEATTLE, March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) has partnered with Oshi Health, a leading virtual clinic specializing in gastrointestinal (GI) conditions that delivers convenient, accessible, whole-person care through a collaborative, multidisciplinary approach. This partnership adds to Accolade's existing GI health partnership with Cylinder and reinforces Accolade's commitment to delivering best-in-class health solutions to customers and their employee and member populations.

GI diseases are a common and costly health issue in the United States, affecting up to 70 million Americans each year and driving an estimated $136 billion in annual healthcare costs. Despite their prevalence and impact, GI conditions are often underprioritized in employer benefit designs, creating challenges for both employers and employees. A key driver of these challenges is the lack of timely access to comprehensive GI care—patients wait an average of 2-3 years for a diagnosis and struggle to find effective treatment, leading to prolonged suffering and missed work. GI conditions and symptoms are the second leading cause of missed work, contributing to increased absenteeism, reduced productivity, and lower employee morale. For individuals, unmanaged GI symptoms cause chronic pain, discomfort, and significant disruptions to daily life – and are the leading cause of avoidable ER visits.

Oshi provides an integrated team of GI specialists – including advanced practice providers, registered dietitians, and licensed psychologists with expertise in gut-brain health – who work together to accelerate the time to diagnosis and to achieve sustainable symptom control. Oshi offers immediate access to high-touch care through telehealth, continuous patient support, and specialized dietary and behavioral health interventions that are proven effective yet hard to find. Oshi's care team can diagnose, prescribe and treat, iterate with patients to identify and address the root causes of symptoms, and coordinate care with patients' primary care physicians. On average, 92% of Oshi patients achieve symptom control within 10 weeks or less and feel equipped to manage their symptoms independently.

"Oshi Health embraces whole-person care for individuals with digestive health challenges," said Dr. Connie Hwang, Accolade's Chief Clinical Officer. "Their focus on personalized treatment plans and timely access to experienced, multidisciplinary GI clinicians aligns with Accolade's commitment to high-quality care. Together, we are empowering employees with specialized expertise and support they need to effectively manage digestive health and improve their overall quality of life."

"Knowing where to turn, in moments of need, is so often the defining moment in patients' journeys – especially for such a complex and under-resourced specialty like gastroenterology. We are excited to partner with Accolade to bring our proven GI care to their customer base," said Sam Holliday, Oshi Health's CEO. "By joining forces, we are increasing access to high-quality GI specialists, empowering more individuals to get the expert support they need to manage their digestive health and achieve lasting control."

Oshi Health is in-network with major insurance plans and its coverage continues to grow. Accolade and Oshi will provide joint customers with purpose-built integrations that address barriers to GI care while raising awareness of Oshi's integrated care model and team of GI clinical specialists.

About Accolade's Trusted Partner Ecosystem

Launched in 2019, Accolade's Trusted Partner Ecosystem accelerates the performance of digital health solutions to improve outcomes across valued categories for employers. Accolade's ecosystem currently consists of 19 partners across 12 categories.

Benefits teams can confidently select from thoroughly vetted solutions and enjoy streamlined contracting and implementation. Through qualified referrals, Accolade drives more engagement with partner solutions, leading to exponentially better health outcomes and better value. Learn more here.

About Accolade

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade's employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinions, and best-in-class care navigation. These offerings are built on a platform engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, X, Instagram, and Facebook.

About Oshi Health

Oshi Health is a redesigned digestive healthcare experience that transforms access to care, the patient experience, clinical outcomes, and healthcare economics. In a high-touch virtual care delivery model, Oshi Health diagnoses and provides integrated treatment for digestive conditions and empowers people to achieve lasting control of their symptoms. As the only national scale virtual GI center of excellence, Oshi Health works with innovative employers, health insurance partners, health systems, and community GI practices to scale access to multidisciplinary care, reduce healthcare costs, and improve the lives of millions of Americans with chronic gastrointestinal diseases. For more information, visit www.oshihealth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/accolade-welcomes-oshi-health-to-trusted-partner-ecosystem-302394552.html

SOURCE Accolade, Inc.

FAQ

What is the success rate of Oshi Health's GI treatment program with ACCD?

92% of Oshi Health patients achieve symptom control within 10 weeks or less of treatment.

How many Americans are affected by GI diseases according to ACCD's partnership announcement?

Up to 70 million Americans are affected by GI diseases each year, resulting in $136 billion in annual healthcare costs.

What is the average waiting time for GI diagnosis that ACCD's partnership aims to reduce?

Patients currently wait an average of 2-3 years for a GI diagnosis.

How will the Oshi Health partnership integrate with ACCD's existing services?

The partnership will provide purpose-built integrations and raise awareness of Oshi's integrated care model, complementing Accolade's existing GI health partnership with Cylinder.